Working… Menu

Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) (SARCOVID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04357808
Recruitment Status : Completed
First Posted : April 22, 2020
Last Update Posted : February 11, 2021
Instituto de Investigación Sanitaria Hospital Universitario de la Princesa
Information provided by (Responsible Party):
Maria del Rosario Garcia de Vicuña Pinedo, Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 30, 2020
Actual Study Completion Date : December 4, 2020